News Headlines

Display #
Title
Clinical trial shows experimental drug's ability to knock down pancreatic cancer's defense
Internet withdrawal increases heart rate and blood pressure
Meet the 31-Year Old Worth $3 Billion Helping Drug Companies Like Bristol-Myers Squibb and Pfizer Market in Doctors’ Offices
At ASCO 2017 clinicians present new evidence about Watson cognitive technology and cancer care
European Commission Approves Brineura, the First Treatment for CLN2 Disease, a Form of Batten Disease and Ultra-Rare Brain Disorder in Children
Massachusetts’ Cellanyx Develops New Method to Culture Primary Prostate Cells
EU approves Biogen’s Spinraza for lead genetic cause of infant death
Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients
Philips in deals with U.S. hospitals on use of its gene data platform for cancer research
IT Transformation and Cloud Content Management for MedTech, Biotechnology and Pharmaceutical Companies
Gilead’s HIV drug meets goal in four late-stage studies
Novartis has assets to sell, investors wary of what it might buy
Merck Receives FDA Approval of Isentress HD
Bay Area Biotech, J&J Ink IBS Deal
Germany’s Evotec Plans to Hire Scientists and Execs at New U.S. HQ
European Commission Approves Pfizer’s Trumenba to Help Prevent Meningococcal Group B Disease in Adolescents and Adults
FDA approves first generic Strattera for the treatment of ADHD
Anyone can become more curious. Is that true?
Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions
Some heart attack patients may not benefit from beta blockers
Array BioPharma and Bristol-Myers Squibb announce strategic collaboration
U.S. Alzheimer’s deaths jump 54 percent
Pfizer Biosimilar Recommended for U.S. Approval
Walking linked to improved brain function
Isolated Greek villages reveal genetic secrets that protect against heart disease
New FDA Head Lifts Hiring Freeze, Takes Aim at the Next Martin Shkreli and Marathon Pharma
Biocryst Stock Caught Fire After Reporting Positive Phase II HAE Data
Making biological drugs with spider silk protein
Journalist Sues FDA for Documents Related to Sarepta’s DMD Drug
Kite NHL Drug Receives FDA Priority Review